Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine in elderly patients with major depressive disorder
2009-011795-29Phase 3Completed
- Sponsor
- Servier
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Agomelatine with Placebo (2 arms). Primary endpoint: HAM-D-17 total score. Started Jul 2009; status: completed.
02
Drugs
agomelatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2009-011795-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011795-29.